Literature DB >> 29849196

The management of malignant pleural mesothelioma in the USA 2004-13-a decade of lost opportunity?

David A Waller1.   

Abstract

Entities:  

Year:  2018        PMID： 29849196      PMCID： PMC5949425          DOI： 10.21037/jtd.2018.04.63

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  19 in total

1.  The MARS feasibility trial: conclusions not supported by data.

Authors:  Walter Weder; Rolf A Stahel; Paul Baas; Urania Dafni; Marc de Perrot; Brian C McCaughan; Takashi Nakano; Harvey I Pass; Bruce W S Robinson; Valerie W Rusch; David J Sugarbaker; Nico van Zandwijk
Journal:  Lancet Oncol       Date:  2011-11       Impact factor: 41.316

2.  The need for randomized trials in mesothelioma: let's walk the talk.

Authors:  Tom Treasure; Suresh Senan
Journal:  Oncologist       Date:  2011-02-23

3.  The Mars trial: resolution of the surgical controversies in mesothelioma?

Authors:  Valerie W Rusch
Journal:  J Thorac Oncol       Date:  2009-10       Impact factor: 15.609

4.  Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial.

Authors:  P E Van Schil; P Baas; R Gaafar; A P Maat; M Van de Pol; B Hasan; H M Klomp; A M Abdelrahman; J Welch; J P van Meerbeeck
Journal:  Eur Respir J       Date:  2010-06-04       Impact factor: 16.671

5.  Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma.

Authors:  Joseph S Friedberg; Melissa J Culligan; Rosemarie Mick; James Stevenson; Stephen M Hahn; Daniel Sterman; Salman Punekar; Eli Glatstein; Keith Cengel
Journal:  Ann Thorac Surg       Date:  2012-05       Impact factor: 4.330

Review 6.  Trials in malignant mesothelioma. LCSG 851 and 882.

Authors:  V W Rusch
Journal:  Chest       Date:  1994-12       Impact factor: 9.410

7.  Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.

Authors:  Lee M Krug; Harvey I Pass; Valerie W Rusch; Hedy L Kindler; David J Sugarbaker; Kenneth E Rosenzweig; Raja Flores; Joseph S Friedberg; Katherine Pisters; Matthew Monberg; Coleman K Obasaju; Nicholas J Vogelzang
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544

8.  Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.

Authors:  Rolf A Stahel; Oliver Riesterer; Alexandros Xyrafas; Isabelle Opitz; Michael Beyeler; Adrian Ochsenbein; Martin Früh; Richard Cathomas; Kristiaan Nackaerts; Solange Peters; Christoph Mamot; Alfred Zippelius; Carlo Mordasini; Clemens B Caspar; Katrin Eckhardt; Ralph A Schmid; Daniel M Aebersold; Oliver Gautschi; Wolfgang Nagel; Michael Töpfer; Jerome Krayenbuehl; Karin Ribi; Ilja Ciernik; Walter Weder
Journal:  Lancet Oncol       Date:  2015-11-02       Impact factor: 41.316

9.  Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study.

Authors:  Tom Treasure; Loic Lang-Lazdunski; David Waller; Judith M Bliss; Carol Tan; James Entwisle; Michael Snee; Mary O'Brien; Gill Thomas; Suresh Senan; Ken O'Byrne; Lucy S Kilburn; James Spicer; David Landau; John Edwards; Gill Coombes; Liz Darlison; Julian Peto
Journal:  Lancet Oncol       Date:  2011-06-30       Impact factor: 41.316

10.  British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma.

Authors:  Ian Woolhouse; Lesley Bishop; Liz Darlison; Duneesha De Fonseka; Anthony Edey; John Edwards; Corinne Faivre-Finn; Dean A Fennell; Steve Holmes; Keith M Kerr; Apostolos Nakas; Tim Peel; Najib M Rahman; Mark Slade; Jeremy Steele; Selina Tsim; Nick A Maskell
Journal:  Thorax       Date:  2018-03       Impact factor: 9.139
View more
  2 in total

1.  Workshop summary: Potential usefulness and feasibility of a US National Mesothelioma Registry.

Authors:  Kristin J Cummings; Michael J Becich; David J Blackley; Dennis Deapen; Robert Harrison; Raffit Hassan; S Jane Henley; Mary Hesdorffer; D Kevin Horton; Jacek M Mazurek; Harvey I Pass; Emanuela Taioli; Xiao-Cheng Wu; Marjorie G Zauderer; David N Weissman
Journal:  Am J Ind Med       Date:  2019-11-19       Impact factor: 2.214

2.  Expression of estrogen receptor beta (ERβ) and its prognostic value in pleural mesothelioma.

Authors:  Jeronimo Rafael Rodríguez-Cid; Orlando García-Acevedo; Javier Benjamin-Contreras; Diana Bonilla-Molina; Rodrigo Rafael Flores-Mariñelarena; Luis Martínez-Barrera; Jorge Arturo Alatorre-Alexander; Carla Paola Sanchez-Ríos; Maria Del Rosario Flores-Soto; Patricio Javier Santillan-Doherty; Erika Sagrario Peña-Mirabal
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.